Literature DB >> 12813620

Angiography of hepatic vascular malformations associated with hereditary hemorrhagic telangiectasia.

Manabu Hashimoto1, Etuko Tate, Toshiaki Nishii, Jiro Watarai, Takanobu Shioya, Robert I White.   

Abstract

PURPOSE: To describe the angiographic features of hepatic involvement in hereditary hemorrhagic telangiectasia (HHT), particularly the presence of portovenous shunts.
METHODS: We reviewed the angiographic findings of seven patients with HHT. The patients comprised three women and four men with a mean age of 51 years.
RESULTS: Intrahepatic telangiectasias were found in all seven patients and shunts between three vascular channels were found in six of seven patients. In the four patients who had portovenous shunts combined with arterioportal shunts, the portovenous shunts were large. Three patients had no portovenous shunts. Two of these patients had arteriovenous shunts, and one had no shunt. The mean age (69 years) of the patients with portovenous shunts was older than those without portovenous shunts (26 years).
CONCLUSIONS: Hepatic vascular lesions in HHT are varied, ranging from telangiectasias to large shunts between three vascular channels. In an advanced stage of involvement, large portovenous shunts are present.

Entities:  

Mesh:

Year:  2003        PMID: 12813620     DOI: 10.1007/s00270-002-1507-y

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  6 in total

1.  Radiological evaluation with Doppler sonography and multidetector CT angiography in congenital hepatic arteriovenous malformation in a newborn.

Authors:  Ibrahim Adaletli; Sebuh Kurugoglu; Fahrettin Kilic; Osman Faruk Senyuz; Sergulen Dervisoglu
Journal:  Pediatr Radiol       Date:  2006-09-14

2.  Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry.

Authors:  Jan Lerut; Giuseppe Orlando; René Adam; Carlo Sabbà; Robert Pfitzmann; Jurgen Klempnauer; Jacques Belghiti; Jacques Pirenne; Thierry Thevenot; Christian Hillert; Colin M Brown; Dominique Gonze; Vincent Karam; Olivier Boillot
Journal:  Ann Surg       Date:  2006-12       Impact factor: 12.969

Review 3.  Hereditary haemorrhagic telangiectasia: a cause of preventable morbidity and mortality.

Authors:  A P Brady; M M Murphy; T M O'Connor
Journal:  Ir J Med Sci       Date:  2008-10-16       Impact factor: 1.568

4.  Treatment of high output cardiac failure by flow-adapted hepatic artery banding (FHAB) in patients with hereditary hemorrhagic telangiectasia.

Authors:  A Koscielny; W A Willinek; A Hirner; M Wolff
Journal:  J Gastrointest Surg       Date:  2007-11-20       Impact factor: 3.452

Review 5.  Diagnostic imaging in the study of visceral involvement of hereditary haemorrhagic telangiectasia.

Authors:  M Memeo; A Scardapane; R De Blasi; C Sabbà; A Carella; G Angelelli
Journal:  Radiol Med       Date:  2008-05-13       Impact factor: 3.469

6.  Liver Findings in Patients with Hereditary Hemorrhagic Telangiectasia.

Authors:  Wenyan Song; Dawei Zhao; Hongjun Li; Jinli Ding; Ning He; Yu Chen
Journal:  Iran J Radiol       Date:  2016-06-22       Impact factor: 0.212

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.